Yes, HBsAg Testing is Mandatory
All pregnant women must be screened for hepatitis B surface antigen (HBsAg) regardless of their anti-HBs antibody status, including those with low anti-HBs titers. 1, 2
Why Low Anti-HBs Does Not Eliminate the Need for HBsAg Testing
The presence of low anti-HBs antibodies does not reliably exclude active HBV infection for several critical reasons:
Anti-HBs titers do not strictly correlate with neutralizing activity - Recent evidence demonstrates that IU/mL values alone are insufficient to assess true protective immunity, and neutralization capacity varies significantly based on vaccine type and individual immune response 3
HBsAg-positive individuals can occasionally have detectable anti-HBs - This occurs in certain infection states and with immune escape variants, making anti-HBs an unreliable sole marker for excluding infection 4
Low anti-HBs titers indicate waning immunity - Titers below 100 IU/L are associated with loss of protection and potential for infection, particularly in high-risk scenarios 5
Universal Screening Protocol
HBsAg screening must be performed in each pregnancy at the first prenatal visit, regardless of:
- Previous HBV vaccination status
- Previous negative HBsAg results
- Current anti-HBs antibody levels 1
This universal approach is mandated because:
Perinatal transmission prevention is critical - 30-40% of chronic HBV infections result from mother-to-child transmission, and chronic infection leads to cirrhosis and hepatocellular carcinoma 1
Screening sensitivity and specificity exceed 98% - HBsAg immunoassays are highly accurate 1
Timely intervention is lifesaving - Infants born to HBsAg-positive mothers require hepatitis B vaccine and immunoglobulin within 12 hours of birth, which reduces transmission risk by >90% 1, 6
Additional Testing for HBsAg-Positive Women
If HBsAg testing is positive, further workup includes:
- HBeAg status
- HBV DNA quantification (critical for determining antiviral prophylaxis need)
- Liver function tests
- Assessment for advanced fibrosis or cirrhosis 2, 6
Women with HBV DNA >200,000 IU/mL or HBeAg-positive status require tenofovir disoproxil fumarate starting at 24-28 weeks gestation to prevent intrauterine transmission 2
Common Pitfall to Avoid
Do not assume that any level of anti-HBs antibodies—even if previously documented—exempts a pregnant woman from HBsAg screening. The consequences of missing active HBV infection include preventable chronic infection in the newborn with lifelong morbidity and mortality risks 1, 6.